Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.839,92
0,68%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Hepion Pharmaceuticals Inc (HEPA) Hepion Pharmaceuticals Inc (HEPA) Notizie

Hepion Pharmaceuticals Inc

HEPA
1,37
0,08 (6,20%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/4/202422:30GLOBEHepion Pharmaceuticals Initiates Wind-Down Activities in..
16/2/202415:02EDGAR2Form 8-K - Current report
16/2/202414:00GLOBEHepion Pharmaceuticals Announces Exercise of Warrants for..
14/2/202421:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/1/202423:15GLOBEHepion Pharmaceuticals to Present at NASH-TAG 2024
03/1/202422:30EDGAR2Form 8-K - Current report
07/12/202314:00GLOBEHepion Pharmaceuticals Announces Restructuring Plan to..
28/11/202322:15GLOBEHepion Pharmaceuticals to Present at the 7th Obesity & NASH..
13/11/202322:05GLOBEHepion Pharmaceuticals Announces Major Reductions in Liver..
10/11/202314:50GLOBEHepion Pharmaceuticals Schedules Conference Call to Review..
09/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
25/10/202314:30GLOBEHepion Pharmaceuticals’ Rencofilstat Demonstrates..
29/9/202314:00GLOBEHepion Pharmaceuticals Announces $5.0 Million Registered..
21/9/202322:05GLOBEHepion Pharmaceuticals to Participate in 2023 Cantor Global..
21/9/202314:00GLOBENew Anti-Cancer Opportunities Revealed for Hepion..
19/9/202315:00GLOBEHepion Pharmaceuticals Discovers Novel Rencofilstat Action..
18/9/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202314:45GLOBERencofilstat Produces Positive Outcomes in Translational..
06/9/202322:40EDGAR2Form 8-K - Current report
06/9/202322:30GLOBEHepion Pharmaceuticals Announces Management Changes
24/7/202322:04EDGAR2Form 8-K - Current report
21/7/202322:41EDGAR2Form 8-K - Current report
21/7/202322:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/6/202322:45GLOBEHepion Pharmaceuticals to Present Two Posters at EASL..
15/6/202314:22GLOBEHepion Pharmaceuticals Announces Passing of Key Safety..
24/5/202322:45GLOBEHepion Pharmaceuticals to Highlight AI-POWR™ at the 2023..
22/5/202313:00GLOBEHepion Pharmaceuticals’ Phase 2 ‘ALTITUDE-NASH’ Trial..
19/5/202322:05GLOBEHepion Pharmaceuticals Schedules Conference Call to Review..
10/5/202317:15GLOBEHepion Pharmaceuticals, Inc. Announces Reverse Stock Split
Apertura: 1,29 Min: 1,27 Max: 1,44
Chiusura: 1,29

La tua Cronologia

NASDAQ
HEPA
Hepion Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network